Work

Evaluating Basophil Histamine Content as a Biomarker for Omalizumab Responsiveness in Chronic Spontaneous Urticaria

Year: 2026

Type: article

Abstract: Summary Our study confirms an association between basophil histamine content and features of type IIb CSU. However, this biomarker is not suitable for predicting omalizumab treatment response or treatment course.

Source: Clinical & Experimental Allergy

DOI: 10.1111/cea.70327

Authors: Ditte Georgina Zhang, Katrine Baumann, Clive Grattan, Per Stahl Skov, Simon Francis Thomsen

Institutions: Bispebjerg Hospital, Guy's Hospital, University of Copenhagen

Language: English

Topic: Urticaria and Related Conditions

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,760

OpenAlex ID: W7156223095

FWCI:

Cites: 4

Cited by:

Related to: